5 Biotech Stocks with Biggest Upside

Page 5 of 5

1. Zai Lab Limited (NASDAQ:ZLAB)

Average Target Price: $70.21

Potential Upside: 145.1%

Number of Hedge Fund Holders: 23

Value of Hedge Fund Holdings: $222,428,960

Zai Lab Limited (NASDAQ:ZLAB) is a Shanghai, China-based biopharmaceutical company focused on bringing innovative medicines to the Chinese and global markets.

Zai Lab Limited (NASDAQ:ZLAB) licenses or acquires late-stage drug candidates from Western biopharma companies and develops and commercializes them in Greater China. The company has licensed products like Zejula (niraparib) for ovarian cancer and Optune for glioblastoma, both licensed from GSK and Novocure, respectively. The pipeline of Zai Lab Limited (NASDAQ:ZLAB) comprises drugs for cancer, autoimmune disorders, and infectious diseases.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also take a peek at the 15 Highest Yielding Dividend Stocks You Can Buy Today and the Long-Term Returns of Nelson Peltz’s Activist Targets.

Page 5 of 5